论文部分内容阅读
吗导敏(Molsidomine)是一种较新的抗心绞痛药物。Racker等将其与氨酰心安(Atenolol)联合治疗稳定性劳力型心绞痛,取得了更加显著的疗效。Schmutrler等对此给予较高的评价。至今,国内尚未见这方面的报道。为进一步确定其疗效,对我院1986年3月至1988年3月确诊为冠心病的99例患者,分成二组,分别采用吗导敏加氨酰心安与复方丹参注射液加低分子右旋糖酐进行治疗,并对其疗效进行对比观察,初步获得了
Molsidomine is a newer anti-anginal drug. Racker, etc. combined with Atenolol in the treatment of stable labor angina pectoris, and achieved more significant effect. Schmutrler et al gave a high rating. So far, no reports of this aspect have been seen in China. To further determine the efficacy of our hospital from March 1986 to March 1988 diagnosed with coronary heart disease in 99 patients were divided into two groups, respectively, the use of sensitive allergy to danshen injection and Danshen injection plus dextran Treatment, and its efficacy compared to observe, initially obtained